Advair/GlaxoSmithKline
Keywords: business, strategic, healthcare, analysis, size, competitive, trends, information
Full Report Price:
0.00
Delivery: Immediate Online Access
Publication Date: 01-MAY-07
Pages: 1
Format:
|
 |
Report DescriptionThe Food and Drug Administration recently questioned whether a survival benefit seen among patients treated with GlaxoSmithKline PLC's Advair was strong enough to allow the agency to approve a new indication for the product. |
|
|
|
Knowledge Source Research Products |
|
Browse other Knowledge Source industry research products:
Health Care Market Overviews
BusIntell Reports
Spotlight
|
About Knowledge Source |
|
Knowledge Source On-Line, since 1989, has delivered healthcare business information and analyses services to executives who seek a competitive edge. Knowledge Source provides healthcare information, syntheses, analysis and presentation services to busy managers who seek actionable market knowledge about clients, competitors, industries or markets in a world with an over-abundance of data. |
|
|
|
|
